Publications

Supplementary Table S5 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the Mipra Trial

AuthID
P-015-D0E

Author(s)

Elía, A

Saldain, L

Vanzulli, SI

Helguero, LA

Lamb, CA

Fabris, V

Pataccini, G

Martínez-Vazquez, P

Burruchaga, J

Caillet-Bois, I

[+4]·

Lovisi, S

Abascal, MF

Novaro, V

Sánchez, J

Muñoz, J

Belizán, JM

Abba, MC

Gass, H

Rojas, P

Lanari, C

View all authors

Document Type

Unpublished

Year published

2023

Published

Indexing

Crossref^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1158/1078-0432.22490249

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

All authors

Name Order	Name	Name Order	Name	Name Order	Name
1	Elía, A;	2	Saldain, L;	3	Vanzulli, SI;
4	Helguero, LA;	5	Lamb, CA;	6	Fabris, V;
7	Pataccini, G;	8	Martínez-Vazquez, P;	9	Burruchaga, J;
10	Caillet-Bois, I;	11	Spengler, E;	12	Acosta Haab, G;
13	Liguori, M;	14	Castets, A;	15	Lovisi, S;
16	Abascal, MF;	17	Novaro, V;	18	Sánchez, J;
19	Muñoz, J;	20	Belizán, JM;	21	Abba, MC;
22	Gass, H;	23	Rojas, P;	24	Lanari, C;

Supplementary Table S5 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the Mipra Trial

Useful Links

Get Help

Federated Authentication (Click on the image)

Supplementary Table S5 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the Mipra Trial

Useful Links

Get Help